Want to see HK:1450 full AI Analyst Report?
Top Page
Century Sage Scientific Holdings Ltd
(1450)
Select Model
Select Model
Rating:77Outperform
Price Target:
HK$0.85
▲(6.37% Upside)
Action:Reiterated
Date:08/01/26
The score is primarily driven by improved financial performance (scaled revenue, sustained profitability, and lower leverage), supported by favorable valuation (moderate P/E and high dividend yield). Technicals are constructive with the price above key moving averages, while margin compression and uneven cash-flow consistency temper the overall rating.
Positive Factors
Revenue and Profitability Growth
Sharp revenue expansion alongside a transition to sustained operating and net profitability indicates stronger commercial scale and improved business economics. If maintained, this progress can support reinvestment, reinforce the company’s competitive position, and provide a more durable earnings base over the next several quarters.
Negative Factors
Margin Compression
Falling gross, operating, and net margins show that higher sales have not translated proportionally into retained profit. Rising costs or pricing pressure could limit operating leverage, weaken earnings growth, and make the recent profitability improvement less durable if the trend continues.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Profitability Growth
Sharp revenue expansion alongside a transition to sustained operating and net profitability indicates stronger commercial scale and improved business economics. If maintained, this progress can support reinvestment, reinforce the company’s competitive position, and provide a more durable earnings base over the next several quarters.
Read all positive factors
Century Sage Scientific Holdings Ltd (1450) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.10B
Dividend Yield6.67%
Average Volume (3M)329.06K
Price to Earnings (P/E)7.3
Beta (1Y)0.55
Revenue Growth35.78%
EPS Growth131.58%
CountryHK
Employees1,495
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.09
Shares Outstanding1,407,203,100
10 Day Avg. Volume182,518
30 Day Avg. Volume329,060
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)2.65
Price to Sales (P/S)0.95
P/FCF Ratio4.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$2.33B
Century Sage Scientific Holdings Ltd Business Overview & Revenue Model
Company Description
Be Friends Holding Ltd. functions as an investment firm, concentrating on providing integrated hardware and software solutions tailored for all-media applications. The company's activities are organized into distinct divisions: New Media Services,...
Century Sage Scientific Holdings Ltd Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.64B | 1.49B | 1.25B | 1.07B | 425.61M | 202.79M |
| Gross Profit | 656.95M | 603.23M | 599.30M | 566.91M | 189.80M | 60.33M |
| EBITDA | 179.36M | 140.67M | 119.87M | 184.30M | 19.76M | -22.52M |
| Net Income | 119.37M | 90.22M | 81.71M | 119.46M | -9.21M | -61.62M |
Balance Sheet | ||||||
| Total Assets | 1.08B | 946.26M | 923.92M | 754.59M | 446.91M | 422.68M |
| Cash, Cash Equivalents and Short-Term Investments | 475.39M | 360.53M | 113.32M | 149.54M | 50.93M | 111.06M |
| Total Debt | 130.29M | 93.33M | 252.83M | 168.96M | 151.23M | 182.62M |
| Total Liabilities | 520.16M | 414.28M | 510.21M | 452.88M | 343.92M | 334.29M |
| Stockholders Equity | 561.71M | 532.02M | 418.99M | 297.51M | 93.30M | 65.80M |
Cash Flow | ||||||
| Free Cash Flow | 337.16M | 351.21M | -45.69M | 167.14M | -6.90M | 7.43M |
| Operating Cash Flow | 341.34M | 357.92M | -27.58M | 182.99M | -2.08M | 7.81M |
| Investing Cash Flow | -224.59M | -136.97M | -58.44M | -74.47M | 32.34M | 4.28M |
| Financing Cash Flow | 44.95M | -19.90M | 52.47M | -10.28M | -34.83M | 36.10M |
Century Sage Scientific Holdings Ltd Technical Analysis
Negative
0.80
Price Trends
0.80
Negative
0.77
Negative
0.85
Negative
Market Momentum
-0.01
Positive
35.37
Neutral
14.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1450, the sentiment is Negative. The current price of 0.8 is below the 20-day moving average (MA) of 0.81, above the 50-day MA of 0.80, and below the 200-day MA of 0.85, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 35.37 is Neutral, neither overbought nor oversold. The STOCH value of 14.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1450.
Century Sage Scientific Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.10B | 7.26 | 21.83% | 6.67% | 35.78% | 131.58% | |
64 Neutral | HK$2.13B | 342.36 | 0.76% | ― | -2.29% | -92.53% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | HK$2.41B | 11.35 | 7.63% | 3.49% | 16.99% | 126.15% | |
51 Neutral | HK$2.82B | -35.28 | -5.91% | ― | ― | ― | |
46 Neutral | HK$567.96M | -18.90 | -8.63% | ― | -12.45% | -103.53% | |
44 Neutral | HK$132.44M | 28.24 | -8.43% | ― | 67.24% | ― |
* Technology Sector Average
HK:1450
Century Sage Scientific Holdings Ltd
0.75
-0.14
-15.64%
HK:2392
Xuan Wu Cloud Technology Holdings Limited
1.04
-0.37
-26.24%
HK:8156
Sinopharm Tech Holdings Limited
0.21
-0.04
-16.40%
HK:9885
YSB Inc.
3.58
-5.42
-60.21%
HK:2576
Zhejiang Taimei Medical Technology Co Ltd Class H
4.77
0.22
4.96%
HK:2571
Beijing Saimo Technology Co. Ltd. Class H
16.00
3.24
25.39%
Century Sage Scientific Holdings Ltd Corporate Events
Be Friends Holding Posts Strong Interim Growth as AI-Driven Strategy Meets Tighter E-Commerce Rules
Aug 21, 2026
Be Friends Holding Limited reported solid interim growth in 2026 as its New Media Services business drove revenue to RMB770.5 million, a 13.9% year-on-year increase, with gross profit up 9.6% to RMB324.4 million. Profit for the period surged 53.5%...
Be Friends Holding Sets Board Meeting to Review Interim Results and Dividend
Aug 11, 2026
Be Friends Holding Limited has scheduled a board meeting for 21 August 2026 to review and approve the group’s unaudited consolidated interim results for the six months ended 30 June 2026. The board will also consider the potential declaratio...
Be Friends Holding Forecasts Profit Surge on AI-Driven Live-Streaming Growth
Aug 5, 2026
Be Friends Holding Limited has issued a positive profit alert, projecting net profit of approximately RMB86 million to RMB93 million for the six months ended 30 June 2026. This compares with about RMB56.4 million a year earlier, implying a robust ...
Be Friends Holding Reports Decline in GMV as Live-Streaming E-Commerce Growth Cools
Jul 9, 2026
Be Friends Holding Limited reported that its total gross merchandise volume in the second quarter of 2026 fell about 11.2% year-on-year to roughly RMB3.36 billion, reflecting softer performance in its live-streaming e-commerce operations. For the ...
Be Friends Holding Wins Strong Shareholder Backing at AGM, Declares Final Dividend
Jun 16, 2026
Be Friends Holding Limited reported that all resolutions tabled at its 16 June 2026 annual general meeting were approved by shareholders, including the adoption of the 2025 audited financial statements and the declaration of a final dividend of HK...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.